Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,381 | -2,284 | 906 | -11,831 | -8,410 |
| Depreciation Amortization | 65 | 42 | 21 | 66 | 47 |
| Other Working Capital | 1,046 | 706 | 393 | 234 | 162 |
| Other Operating Activity | 2,657 | -993 | -2,617 | 4,672 | 3,470 |
| Operating Cash Flow | $-3,613 | $-2,528 | $-1,297 | $-6,860 | $-4,731 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -8 | -5 | -77 | -72 |
| Purchase Sale Intangibles | -76 | -52 | -34 | -117 | -62 |
| Other Investing Activity | -76 | -52 | -34 | -117 | -62 |
| Investing Cash Flow | $-89 | $-60 | $-39 | $-194 | $-134 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,220 | 903 | N/A | 4,553 | 2,711 |
| Financing Cash Flow | $1,220 | $903 | $N/A | $4,553 | $2,711 |
| Beginning Cash Position | 4,903 | 4,903 | 4,903 | 7,404 | 7,404 |
| End Cash Position | 2,421 | 3,218 | 3,567 | 4,903 | 5,250 |
| Net Cash Flow | $-2,483 | $-1,685 | $-1,336 | $-2,501 | $-2,154 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,613 | -2,528 | -1,297 | -6,860 | -4,731 |
| Capital Expenditure | -13 | -8 | -5 | -77 | -72 |
| Free Cash Flow | -3,627 | -2,537 | -1,302 | -6,937 | -4,803 |